Multiple Sclerosis Clinical Trial

MS PATHS Normative Sub-Study

Summary

The primary objective of this study is to determine the normative range of brain volume and brain volume change in healthy control (HC) participants whose age, race, and gender distribution is approximately matched to the age, race, and gender distribution of patients with Multiple Sclerosis (MS) enrolled in Study 888MS001. The secondary objective is to use the results of the primary endpoint to ensure consistency of brain volume measurements across MS PATHS centers.

View Eligibility Criteria

Eligibility Criteria

Key Inclusion Criteria

Ability to understand the purpose and risks of the study and provide signed and dated informed consent and authorization to use protected health information in accordance with national and local participant privacy regulations.

Key Exclusion Criteria

History of human immunodeficiency virus.
Confirmed or suspected pregnancy.
Diagnosis of migraine requiring medication or any other participant-reported diagnosis of a neurological disease or condition (e.g., stroke, transient ischemic attack, epilepsy, brain infection, brain surgery, prior head injury or concussion, or brain tumor).
Any participant-reported diagnosis of an autoimmune disorder (e.g., rheumatoid arthritis, Sjögren's syndrome, scleroderma, or systemic lupus erythematosus).
Standard MRI exclusion criteria, including claustrophobia, inability to lay still in the magnet (e.g., tremor), or any type of implanted metal in the body that would be affected by the strong magnetic field.

NOTE: Other protocol defined Inclusion/Exclusion criteria may apply

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

246

Study ID:

NCT02996084

Recruitment Status:

Completed

Sponsor:

Biogen

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 4 Locations for this study

See Locations Near You

Johns Hopkins University
Baltimore Maryland, 21287, United States
Washington University
Saint Louis Missouri, 63110, United States
University of Rochester Medical Center
Rochester New York, 14642, United States
The Cleveland Clinic Foundation
Cleveland Ohio, 44195, United States
University Hospital Carl Gustav Carus Dresden
Dresden , , Germany
Multiple Sclerosis Centre of Catalonia (Cemcat) Vall d'Hebron Hospital
Barcelona , , Spain

How clear is this clinincal trial information?

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

246

Study ID:

NCT02996084

Recruitment Status:

Completed

Sponsor:


Biogen

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.